Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding Vincerx Pharma, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 14 | 1 | −13 |
| Shares | 220.6K | 50 | −220.6K (−100.0%) |
| Value | $116.8K | $2 | −$116.8K (−100.0%) |
New holders (1)
Institutions that held Vincerx Pharma, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank & Trust Co | 50 | $2 | 0.00% |
Sold out (14)
Institutions that held Vincerx Pharma, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Sage Rhino Capital LLC | 85,170 | $45.1K |
| Citadel Advisors LLC | 42,777 | $22.6K |
| Goldman Sachs Group Inc | 31,567 | $16.7K |
| Geode Capital Management, LLC | 19,285 | $10.2K |
| Vanguard Group Inc | 14,317 | $7.57K |
| Two Sigma Securities, LLC | 11,053 | $5.85K |
| Millennium Management LLC | 10,798 | $5.72K |
| Tower Research Capital LLC (TRC) | 2,997 | $1.59K |
| BlackRock, Inc. | 2,352 | $1.25K |
| UBS Group AG | 142 | $75 |
| Morgan Stanley | 102 | $54 |
| SBI Securities Co., Ltd. | 50 | $26 |
| Bank of America Corp | 15 | $8 |
| JPMorgan Chase & Co | 1 | $1 |